Atypical mycobacterial infection of the orbit (Q41428534)

30 September 2017

title

Atypical mycobacterial infection of the orbit (English)

1 reference

30 September 2017

Klapper SR

1

1 reference

30 September 2017

Patrinely JR

series ordinal

2

1 reference

30 September 2017

Kaplan SL

series ordinal

3

1 reference

30 September 2017

Font RL

series ordinal

4

1 reference

30 September 2017

publication date

1 October 1995

1 reference

30 September 2017

1 reference

30 September 2017

volume

102

1 reference

30 September 2017

issue

10

1 reference

30 September 2017

page(s)

1536-1541

1 reference

An Unusual Acid-Fast Infection of the Knee with Subcutaneous, Abscess-Like Lesions of the Gluteal Region

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Mycobacterium chelonae infection among patients receiving high-flux dialysis in a hemodialysis clinic in California

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Mycobacterium chelonaeCausing Otitis Media in an Ear-Nose-and-Throat Practice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Nontuberculous mycobacterial keratitis. Report of two cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Postoperative mycobacterial endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Endogenous Mycobacterium chelonae endophthalmitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Mycobacterium chelonei and orbital granuloma after tear duct probing

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Infection of the orbit by an atypical mycobacterium.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

MYCOBACTERIA ISOLATED FROM SOIL

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Human infection with atypical acid-fast organisms; report of two cases with pathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Keratitis due to mycobacterium chelonei

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Anonymous mycobacteria in pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Mycobacterium AbscessusInfection in a Puncture Wound

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Ciprofloxacin therapy of Mycobacterium chelonae keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Clinical Usefulness of Amikacin and Doxycycline in the Treatment of Infection Due to Mycobacterium fortuitum and Mycobacterium chelonei

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Disseminated Mycobacterium chelonae ssp. abscessus in an immunocompetent host and with a known portal of entry

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2895%2930834-2

7 January 2021

10.1016/S0161-6420(95)30834-2

Identifiers

DOI

1 reference

30 September 2017

1 reference